Fintel reports that on October 17, 2025, B of A Securities maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...
Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
CRISPR Therapeutics (CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common ...
Baby KJ's medical team intend to ask the FDA to start a clinical trial that would be open to patients with seven different ...
Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...
This interesting study adapts machine learning tools to analyze movements of a chromatin locus in living cells in response to serum starvation. The machine learning approach developed is useful, the ...
The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human ...
Zacks Investment Research on MSN
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Correction: This story was updated at 9:02 a.m. Oct. 2 to correct U.S. Sen. Jim Risch’s statement provided to the Idaho Capital Sun. After members of Congress failed to approve a funding bill late ...
The Tennessee Volunteers are entering by week when it comes to the college football season as they are one of the more promising teams on the offensive side of the football, which is exactly what you ...
What Does the Government Shutdown Mean for Cybersecurity? Your email has been sent On Oct. 1, the US federal government shut down after Congress failed to pass funding for fiscal year 2026. Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results